Mesentech

company

About

Mesentech is a company focused on treating diseases and medical conditions that relate to bone.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Mesentech is a company focused on treating diseases and medical conditions that relate to bone. They are generating a series of products, from different, but complementary approaches that will effectively address currently difficult to treat conditions.

Bone can be one of the most difficult organs to access and treat with medicines. It’s hard surface and low porosity presents challenges in adequately getting drugs to either the bone surface or to its interior. Treatment often requires administering high doses of a drug over extended periods. Not only is achievement of efficacy compromised, but also side- effects may be more prevalent and can limit treatment effectiveness.

Mesentech’s lead technology is a proprietary bone targeting system that can effectively deliver small-molecule and biological drugs to the surface or to the interior of bone. Pre-clinical in-vivo models have confirmed the utility of this technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Mesentech has raised a total of — in funding over 2 rounds. Their latest funding was raised on Nov 10, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 10, 2020 Series Unknown 2 Detail
May 24, 2019 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Mesentech is funded by 3 investors. Charles Hood Foundation and CureDuchenne Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Charles Hood Foundation Series Unknown
CureDuchenne Ventures Series Unknown
Merck Seed